Anti-NBAT
|
- $503 - $598
- Product name: Anti-NBAT
- CAS:
- MF:
- MW: 0
- EINECS:
- MDL Number:
- Synonyms:Anti-SLC3A1, (N-terminal) antibody produced in rabbit;Anti-SLC3A1 antibody produced in rabbit;Anti-ATR1;Anti-CSNU1;Anti-D2H;Anti-NBAT;Anti-FLJ34681;Anti-RBAT
3 prices
Selected condition:
Brand
- Sigma-Aldrich
Package
- 100 μL
- 100μL
- ManufacturerSigma-Aldrich
- Product numberSAB2105525
- Product descriptionAnti-SLC3A1, (N-terminal) antibody produced in rabbit affinity isolated antibody
- Packaging100μL
- Price$503
- Updated2023-01-07
- Buy
- ManufacturerSigma-Aldrich
- Product numberHPA071102
- Product descriptionAnti-SLC3A1 antibody produced in rabbit Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody
- Packaging100 μL
- Price$598
- Updated2025-07-31
- Buy
- ManufacturerSigma-Aldrich
- Product numberHPA038360
- Product descriptionAnti-SLC3A1 antibody produced in rabbit Prestige Antibodies? Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
- Packaging100μL
- Price$598
- Updated2025-07-31
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Sigma-Aldrich | SAB2105525 | Anti-SLC3A1, (N-terminal) antibody produced in rabbit affinity isolated antibody | 100μL | $503 | 2023-01-07 | Buy |
Sigma-Aldrich | HPA071102 | Anti-SLC3A1 antibody produced in rabbit Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody | 100 μL | $598 | 2025-07-31 | Buy |
Sigma-Aldrich | HPA038360 | Anti-SLC3A1 antibody produced in rabbit Prestige Antibodies? Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution | 100μL | $598 | 2025-07-31 | Buy |
Properties
storage temp. :-20°C
form :buffered aqueous glycerol solution
biological source :rabbit
form :buffered aqueous glycerol solution
biological source :rabbit
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|